News

Researchers have developed a mouse model to investigate whether persistent CD30 signaling leads to the development of blood cancers.

A new technique for the decontamination of organs before transplantation using ultraviolet and red light irradiation has been developed.

Despite substantial gains in vaccine coverage, progress has been far from universal in African nations.

An anti-cancer drug has shown promise in slowing or stopping the progression of a typically fatal viral brain infection by altering the "brakes" on the immune system.

Fate Therapeutics, in collaboration with UC San Diego researchers, developed the first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials.

In light of the continuing anti-vaccination movement, a provocative new article provides a comprehensive overview of the potential risks of vaccinating breastfeeding women.

Candida auris, a yeast infection that is resistant to multiple antimicrobial drugs, presents a serious global threat.

A new study reveals for the first time that a common species of seaweed, Laminaria ochroleuca, is a rich source of bacteria with antimicrobial and anticancer activities, and potential new drug candidates.

Tumors are a complex mixture of many different cell types, including immune cells known collectively as tumor-infiltrating myeloid cells. These cells represent alternative targets for immunotherapy, but their role in tumors is still poorly understood. To shed light on this under-examined family of immune cells, researchers used single-cell sequencing to map the landscape of myeloid cells in tumors from patients with lung cancer.

Progress has been made towards developing a vaccine for the Epstein-Barr virus, a herpesvirus that causes infectious mononucleosis and is associated with certain cancers.